VALLERINI, Daniela
 Distribuzione geografica
Continente #
NA - Nord America 7.267
EU - Europa 3.142
AS - Asia 2.682
SA - Sud America 351
AF - Africa 67
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 2
Totale 13.524
Nazione #
US - Stati Uniti d'America 7.173
GB - Regno Unito 984
SG - Singapore 831
CN - Cina 656
IT - Italia 454
SE - Svezia 451
VN - Vietnam 363
HK - Hong Kong 333
DE - Germania 288
BR - Brasile 257
FI - Finlandia 236
RU - Federazione Russa 179
FR - Francia 137
UA - Ucraina 128
TR - Turchia 105
IN - India 91
BG - Bulgaria 50
CA - Canada 46
ID - Indonesia 44
KR - Corea 39
BD - Bangladesh 33
CZ - Repubblica Ceca 32
BE - Belgio 31
NL - Olanda 31
AR - Argentina 29
JP - Giappone 26
ES - Italia 25
IQ - Iraq 25
MX - Messico 24
IE - Irlanda 19
PL - Polonia 18
ZA - Sudafrica 18
AE - Emirati Arabi Uniti 16
LT - Lituania 16
AT - Austria 15
CO - Colombia 14
EC - Ecuador 14
PH - Filippine 14
CL - Cile 13
MA - Marocco 13
UZ - Uzbekistan 13
KE - Kenya 12
PK - Pakistan 11
IR - Iran 10
MY - Malesia 10
EU - Europa 9
AZ - Azerbaigian 8
BZ - Belize 8
RO - Romania 8
SK - Slovacchia (Repubblica Slovacca) 8
VE - Venezuela 8
EG - Egitto 7
PY - Paraguay 6
AL - Albania 5
CY - Cipro 5
DK - Danimarca 5
PS - Palestinian Territory 5
SA - Arabia Saudita 5
UY - Uruguay 5
DZ - Algeria 4
IL - Israele 4
JO - Giordania 4
KG - Kirghizistan 4
PA - Panama 4
TH - Thailandia 4
TN - Tunisia 4
TW - Taiwan 4
BH - Bahrain 3
CH - Svizzera 3
CR - Costa Rica 3
GR - Grecia 3
KZ - Kazakistan 3
LB - Libano 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
EE - Estonia 2
HU - Ungheria 2
JM - Giamaica 2
LV - Lettonia 2
MK - Macedonia 2
NI - Nicaragua 2
NP - Nepal 2
PE - Perù 2
QA - Qatar 2
RS - Serbia 2
SN - Senegal 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
A1 - Anonimo 1
AO - Angola 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CG - Congo 1
CI - Costa d'Avorio 1
DM - Dominica 1
GE - Georgia 1
GN - Guinea 1
GY - Guiana 1
Totale 13.512
Città #
Ashburn 805
Fairfield 801
Southend 686
Santa Clara 554
Singapore 524
Woodbridge 486
Chandler 432
Houston 365
Ann Arbor 344
Hong Kong 329
Seattle 289
San Jose 259
Nyköping 249
Wilmington 235
Cambridge 224
Jacksonville 218
Dearborn 211
Helsinki 174
Modena 129
New York 127
Beijing 126
London 122
Hefei 116
Ho Chi Minh City 116
Los Angeles 103
Hanoi 82
Munich 77
Chicago 68
Fremont 63
Council Bluffs 61
The Dalles 59
San Diego 54
Sofia 49
Princeton 46
Bremen 45
Eugene 44
Izmir 44
Lauterbourg 41
Milan 38
Seoul 36
Moscow 34
Buffalo 32
Des Moines 32
Brussels 27
Jakarta 27
Boardman 26
Dallas 26
Salt Lake City 24
Shanghai 24
São Paulo 24
Frankfurt am Main 23
Orem 23
Da Nang 22
Redwood City 22
Atlanta 20
Tokyo 20
Turku 20
Montreal 18
Dublin 17
Toronto 17
Brooklyn 15
Bologna 14
Chennai 14
Columbus 14
Warsaw 14
Las Vegas 13
Denver 12
Elk Grove Village 12
Haiphong 12
Paris 12
Stockholm 12
Tashkent 12
Kunming 11
Nairobi 11
Tampa 11
Washington 11
Baghdad 10
Brno 10
Dong Ket 10
Hải Dương 10
Phoenix 10
Rome 10
San Francisco 10
Albuquerque 9
Amsterdam 9
Guangzhou 9
Johannesburg 9
Mexico City 9
Miano 9
Poplar 9
Rio de Janeiro 9
Belize City 8
Boston 8
Jinan 8
Kilburn 8
Vienna 8
Detroit 7
Istanbul 7
Lancaster 7
Nanjing 7
Totale 9.719
Nome #
Changes in T-Cell Responses Against Human Herpesvirus-8 Correlate with the Disease Course of Iatrogenic Kaposi's Sarcoma in a Patient with Undifferentiated Arthritis 441
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 418
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 399
B cells and herpesviruses: a model of lymphoproliferation 398
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 391
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 360
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 352
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term Imatinib mesylate treatment. 349
Assessment of aspergillus-specific T cells for diagnosis of invasive aspergillosis in a leukemic child with liver lesions mimicking hepatosplenic candidiasis 343
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 342
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 341
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 340
Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma 335
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 332
Mucorales-specific T cells in patients with hematologic malignancies 326
Diagnosis of invasive aspergillosis by tracking Aspergillus-specific T cells in hematologic patients with pulmonary infiltrates 323
Human herpesvirus 6 latency characterized by high viral load: Chromosomal integration in many, but not all, cells 309
Organising pneumonia mimicking invasive fungal disease in patients with leukaemia. 307
Parvoviruses in blood donors and transplant patients, Italy 304
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 304
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 302
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 301
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 296
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 292
Human Herpesvirus 8 (HHV8) Infection and Related Diseases in Italian Transplant Cohorts. 290
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 281
Diagnosis of aspergillosis: Role of proteomics 281
HHV-6 and atypical lymphoproliferative disorders: are only qualitative molecular examinations sufficient to support a pathogenetic role? 277
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 277
Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma. 273
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 271
"Metodo per la diagnosi e/o il monitoraggio della mucormicosi" - "Method for the diagnosis of and/or monitoring mucormycosis" 269
Identification and characterization of Aspergillus-specific immune responses to diagnose invasive aspergillosis in high risk patients: a multicenter study 263
Indirect Antitumor Effects of Mammalian Target of Rapamycin Inhibitors Against Kaposi Sarcoma in Transplant Patients 261
Prevalence of Human Herpesvirus-6 Chromosomal Integration (CIHHV-6) in Italian Solid Organ and Allogeneic Stem Cell Transplant Patients 260
Mucorles-specific T cells emerge in the course of invasive mucormucosis and may be used as a surrogate diagnostic marker in high-risk patients 260
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 259
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 258
Splenic hyalohyphomycosis, molecularly and immunologically consistent with invasive aspergillosis, in a patient with acute lymphoblastic leukemia. 248
BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia 243
Tumor-targeted immunoliposomal nanosystems to deliver either Cidofovir or Antineoplastic SiRNA against Primary Effusion Lymphoma (PEL) 242
Human herpesvirus 8-associated diseases in solid-organ transplantation: importance of viral transmission from the donor 237
Fatal hemophagocytic syndrome related to active human herpesvirus-8/Kaposi sarcoma-associated herpesvirus infection in human immunodeficiency virus-negative, non-transplant patients without related malignancies 208
KSHV/HHV-8 infection of tubular epithelial cells in transplantation kidney 188
β-HHVs and HHV-8 in Lymphoproliferative Disorders. 183
Identification and validation of diagnostic cut-offs of the ELISpot assay for the diagnosis of invasive aspergillosis in high-risk patients 136
Totale 13.670
Categoria #
all - tutte 47.866
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.866


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021175 0 0 0 0 0 0 0 0 0 0 94 81
2021/20221.124 44 138 143 61 27 41 61 57 96 99 225 132
2022/20231.284 191 180 80 129 197 151 47 108 100 9 51 41
2023/2024778 19 26 63 60 156 100 79 139 14 10 53 59
2024/20252.024 84 32 51 154 363 296 145 124 235 86 157 297
2025/20263.602 315 138 263 343 616 324 585 203 414 335 66 0
Totale 13.670